Fernö M - Search Results

1

Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.

Olsson H, Borg A, Fernö M, Möller TR, Ranstam J. Olsson H, et al. Among authors: ferno m. Cancer Detect Prev. 1991;15(4):265-71. Cancer Detect Prev. 1991. PMID: 1794133

2

Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.

Baldetorp B, Fernö M, Fallenius A, Fallenius-Vecchi G, Idvall I, Olsson H, Sigurdsson H, Akerman M, Killander D. Baldetorp B, et al. Among authors: ferno m. Cytometry. 1992;13(6):577-85. doi: 10.1002/cyto.990130605. Cytometry. 1992. PMID: 1451590 Free article.

3

Flow cytometry DNA analysis and prediction of loco-regional recurrences after mastectomy in breast cancer.

Ewers SB, Attewell R, Baldetorp B, Borg A, Fernö M, Långström E, Rydén S, Killander D. Ewers SB, et al. Among authors: ferno m. Acta Oncol. 1992;31(7):733-40. doi: 10.3109/02841869209083862. Acta Oncol. 1992. PMID: 1476753 Clinical Trial.

4

One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?

Fernö M, Baldetorp B, Ewers SB, Idvall I, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Cytometry. 1992;13(3):241-9. doi: 10.1002/cyto.990130305. Cytometry. 1992. PMID: 1576890 Free article.

5

Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content.

Gustafson P, Willén H, Baldetorp B, Fernö M, Akerman M, Rydholm A. Gustafson P, et al. Among authors: ferno m. Cancer. 1992 Jul 1;70(1):114-9. doi: 10.1002/1097-0142(19920701)70:1<114::aid-cncr2820700119>3.0.co;2-u. Cancer. 1992. PMID: 1606532

6

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.

Borg A, Baldetorp B, Fernö M, Olsson H, Sigurdsson H. Borg A, et al. Among authors: ferno m. Int J Cancer. 1992 Jul 9;51(5):687-91. doi: 10.1002/ijc.2910510504. Int J Cancer. 1992. PMID: 1612775

7

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.

Fernö M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Acta Oncol. 1992;31(2):157-65. doi: 10.3109/02841869209088897. Acta Oncol. 1992. PMID: 1622630

8

Long-term effects of adjuvant tamoxifen and/or radiotherapy. The South Sweden Breast Cancer Trial.

Rydén S, Fernö M, Möller T, Aspegren K, Bergljung L, Killander D, Landberg T. Rydén S, et al. Among authors: ferno m. Acta Oncol. 1992;31(2):271-4. doi: 10.3109/02841869209088914. Acta Oncol. 1992. PMID: 1622645 Clinical Trial.

9

ERBB2 amplification in breast cancer with a high rate of proliferation.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. Borg A, et al. Among authors: ferno m. Oncogene. 1991 Jan;6(1):137-43. Oncogene. 1991. PMID: 1671531

10

Progression of human endometrial adenocarcinoma heterotransplanted into nude mice from hormone-sensitive to hormone resistant growth.

Horvath G, Fernö M, Baldetorp B, Cameron R, Ranstam J. Horvath G, et al. Among authors: ferno m. In Vivo. 1991 Mar-Apr;5(2):185-90. In Vivo. 1991. PMID: 1768790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters